Notice of Knight Therapeutics' Fourth Quarter and Year End 2025 Results Conference Call
Globenewswire·2026-03-12 11:30
MONTREAL, March 12, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its fourth quarter and year end 2025 financial results on Thursday, March 19, 2026 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call. Date: Thursday, March 19, 2026Time: 8:30 a.m. ETTelephone: Toll Free: 1-888-699-1199 o ...